166 related articles for article (PubMed ID: 29713144)
1. Lymphoma-targeted treatment using a folic acid-decorated vincristine-loaded drug delivery system.
Qiu L; Dong C; Kan X
Drug Des Devel Ther; 2018; 12():863-872. PubMed ID: 29713144
[TBL] [Abstract][Full Text] [Related]
2. Combination Treatment of Cervical Cancer Using Folate-Decorated, pH-Sensitive, Carboplatin and Paclitaxel Co-Loaded Lipid-Polymer Hybrid Nanoparticles.
Wang J
Drug Des Devel Ther; 2020; 14():823-832. PubMed ID: 32161442
[TBL] [Abstract][Full Text] [Related]
3. Co-delivery of vincristine and quercetin by nanocarriers for lymphoma combination chemotherapy.
Zhu B; Yu L; Yue Q
Biomed Pharmacother; 2017 Jul; 91():287-294. PubMed ID: 28463792
[TBL] [Abstract][Full Text] [Related]
4. [VCR-loaded nanoparticles as targeted delivery system for the treatment of orbital adenoid cystic carcinoma].
He YJ; Lin TT; Zhu LM; Luo H; Chang J; Zhang H; Zhang HM
Zhonghua Yan Ke Za Zhi; 2010 Sep; 46(9):795-801. PubMed ID: 21092558
[TBL] [Abstract][Full Text] [Related]
5. Targeted delivery and apoptosis induction of CDK-4/6 inhibitor loaded folic acid decorated lipid-polymer hybrid nanoparticles in breast cancer cells.
Rajana N; Sandeep Chary P; Bhavana V; Deshmukh R; Dukka K; Sharma A; Kumar Mehra N
Int J Pharm; 2024 Feb; 651():123787. PubMed ID: 38184023
[TBL] [Abstract][Full Text] [Related]
6. Lymph cancer chemotherapy: delivery of doxorubicin-gemcitabine prodrug and vincristine by nanostructured lipid carriers.
Ni S; Qiu L; Zhang G; Zhou H; Han Y
Int J Nanomedicine; 2017; 12():1565-1576. PubMed ID: 28280326
[TBL] [Abstract][Full Text] [Related]
7. Synergistic combination therapy of lung cancer using paclitaxel- and triptolide-coloaded lipid-polymer hybrid nanoparticles.
Liu J; Cheng H; Han L; Qiang Z; Zhang X; Gao W; Zhao K; Song Y
Drug Des Devel Ther; 2018; 12():3199-3209. PubMed ID: 30288024
[TBL] [Abstract][Full Text] [Related]
8. Vincristine and temozolomide combined chemotherapy for the treatment of glioma: a comparison of solid lipid nanoparticles and nanostructured lipid carriers for dual drugs delivery.
Wu M; Fan Y; Lv S; Xiao B; Ye M; Zhu X
Drug Deliv; 2016 Oct; 23(8):2720-2725. PubMed ID: 26203691
[TBL] [Abstract][Full Text] [Related]
9. Combination Chemotherapy of Lung Cancer - Co-Delivery of Docetaxel Prodrug and Cisplatin Using Aptamer-Decorated Lipid-Polymer Hybrid Nanoparticles.
Wu R; Zhang Z; Wang B; Chen G; Zhang Y; Deng H; Tang Z; Mao J; Wang L
Drug Des Devel Ther; 2020; 14():2249-2261. PubMed ID: 32606595
[TBL] [Abstract][Full Text] [Related]
10. Carboxymethyl-β-cyclodextrin conjugated nanoparticles facilitate therapy for folate receptor-positive tumor with the mediation of folic acid.
Su C; Li H; Shi Y; Wang G; Liu L; Zhao L; Su R
Int J Pharm; 2014 Oct; 474(1-2):202-11. PubMed ID: 25149123
[TBL] [Abstract][Full Text] [Related]
11. Folate-decorated, endostatin-loaded, nanoparticles for anti-proliferative chemotherapy in esophaegeal squamous cell carcinoma.
Adeyemi SA; Choonara YE; Kumar P; du Toit LC; Marimuthu T; Kondiah PPD; Pillay V
Biomed Pharmacother; 2019 Nov; 119():109450. PubMed ID: 31541853
[TBL] [Abstract][Full Text] [Related]
12. Improved therapeutic responses in a xenograft model of human B lymphoma (Namalwa) for liposomal vincristine versus liposomal doxorubicin targeted via anti-CD19 IgG2a or Fab' fragments.
Sapra P; Moase EH; Ma J; Allen TM
Clin Cancer Res; 2004 Feb; 10(3):1100-11. PubMed ID: 14871990
[TBL] [Abstract][Full Text] [Related]
13. Hyaluronic Acid Capped, Irinotecan and Gene Co-Loaded Lipid-Polymer Hybrid Nanocarrier-Based Combination Therapy Platform for Colorectal Cancer.
Wang Z; Zang A; Wei Y; An L; Hong D; Shi Y; Zhang J; Su S; Fang G
Drug Des Devel Ther; 2020; 14():1095-1105. PubMed ID: 32210538
[TBL] [Abstract][Full Text] [Related]
14. Targeted delivery of etoposide to cancer cells by folate-modified nanostructured lipid drug delivery system.
Zhang S; Lu C; Zhang X; Li J; Jiang H
Drug Deliv; 2016 Jun; 23(5):1838-45. PubMed ID: 26879035
[TBL] [Abstract][Full Text] [Related]
15. Pursuing for the better lung cancer therapy effect: Comparison of two different kinds of hyaluronic acid and nitroimidazole co-decorated nanomedicines.
Chen G; Zhang Y; Deng H; Tang Z; Mao J; Wang L
Biomed Pharmacother; 2020 May; 125():109988. PubMed ID: 32059173
[TBL] [Abstract][Full Text] [Related]
16. An investigation of antitumor efficiency of novel sustained and targeted 5-fluorouracil nanoparticles.
Le VM; Wang JJ; Yuan M; Nguyen TL; Yin GF; Zheng YH; Shi WB; Lang MD; Xu LM; Liu JW
Eur J Med Chem; 2015 Mar; 92():882-9. PubMed ID: 25676729
[TBL] [Abstract][Full Text] [Related]
17. In vivo tumor targeting and anti-tumor effects of 5-fluororacil loaded, folic acid targeted quantum dot system.
Bwatanglang IB; Mohammad F; Yusof NA; Abdullah J; Alitheen NB; Hussein MZ; Abu N; Mohammed NE; Nordin N; Zamberi NR; Yeap SK
J Colloid Interface Sci; 2016 Oct; 480():146-158. PubMed ID: 27428851
[TBL] [Abstract][Full Text] [Related]
18. Combination Therapy of Metastatic Castration-Recurrent Prostate Cancer: Hyaluronic Acid Decorated, Cabazitaxel-Prodrug and Orlistat Co-Loaded Nano-System.
Qu Z; Ren Y; Shen H; Wang H; Shi L; Tong D
Drug Des Devel Ther; 2021; 15():3605-3616. PubMed ID: 34447241
[TBL] [Abstract][Full Text] [Related]
19. Folic acid-conjugated amphiphilic alternating copolymer as a new active tumor targeting drug delivery platform.
Li X; Szewczuk MR; Malardier-Jugroot C
Drug Des Devel Ther; 2016; 10():4101-4110. PubMed ID: 28008233
[TBL] [Abstract][Full Text] [Related]
20. Folic acid-tagged protein nanoemulsions loaded with CORM-2 enhance the survival of mice bearing subcutaneous A20 lymphoma tumors.
Loureiro A; Bernardes GJ; Shimanovich U; Sárria MP; Nogueira E; Preto A; Gomes AC; Cavaco-Paulo A
Nanomedicine; 2015 Jul; 11(5):1077-83. PubMed ID: 25791804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]